EUR/CAD1.5726+0.06%GBP/CAD1.8783-0.32%USD/CAD1.4317-0.06%Gold C$/oz5,543BTC C$92,391-3.05%ETH C$2,591-3.76%TSX36,106-0.09%S&P 5007,562-0.40%Dow52,348+0.10%Nasdaq25,136-0.91%BoC rate2.50%
CONNECTICAbusiness & money for founders

Markets

Peptide Development Labs Begins Trading on CSE Following HYTN Spinoff

Connectica newsroom · November 20, 2026

Canadian pharmaceutical firm Peptide Development Labs starts trading as PEPT after complex share restructuring with cannabis company HYTN Innovations.

Peptide Development Labs Begins Trading on CSE Following HYTN Spinoff
Peptide Development Labs Begins Trading on CSE Following HYTN Spinoff — Connectica

Canadian pharmaceutical firm Peptide Development Labs starts trading as PEPT after complex share restructuring with cannabis company HYTN Innovations.

Peptide Development Labs Inc. (CSE: PEPT) began trading on the Canadian Securities Exchange on November 20, 2026, following a complex corporate restructuring with cannabis company HYTN Innovations Inc. (CSE: HYTN). The spinoff arrangement, approved by HYTN shareholders on November 12, exchanged each HYTN share for one new HYTN share plus 0.0556 PEPT shares.

The Vancouver-based pharmaceutical developer focuses on peptide-based drug candidates, particularly its BPC-157 subcutaneous treatment for refractory ligament disorders. The company emphasizes GMP-controlled manufacturing and clinical development pathways, differentiating itself from HYTN's cannabis-derived cannabinoid business.

HYTN completed a share reclassification on November 17, converting existing shares to Class A then Class B shares before redesignating them as new common shares. This maintained shareholders' proportional ownership while creating the separate PEPT equity. HYTN continues trading under its existing ticker with updated CUSIP 40443L203.

The listing provides Canadian investors exposure to specialty pharma development through PEPT's clinical-stage pipeline. However, the companies caution about risks including regulatory hurdles and reliance on third-party manufacturers in forward-looking statements. Market makers can apply to facilitate trading in the new listing through the CSE.

Reported with files from CSE - Bulletins, Newswire Canada (via Financial Post).

Connectica provides information only, not financial, investment or legal advice.